Syndax Pharmaceuticals Inc (SNDX)
SG&A Expense Growth
10.51%
Quarterly · Period ending:
SNDX SG&A Expense Growth
Latest reported10.51%period ending
Latest reported10.51%period ending
SNDX Quarterly SG&A Growth (QoQ) (0.00% → 10.51%)
Latest values, visible window
High-resolution chart · PNG
SNDX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 10.5113% | |
| -24.7171% | |
| 11.1584% | |
| 2.5385% | |
| 6.7607% | |
| 8.8644% | |
| 21.1663% | |
| 7.0369% | |
| 26.2314% | |
| 1.0668% | |
| 31.9145% | |
| 15.7838% | |
| 24.6886% | |
| 17.3568% | |
| 23.6893% | |
| 3.1289% | |
| 16.8812% | |
| -1.3137% | |
| 1.8527% | |
| 16.4156% | |
| 2.9972% | |
| 20.2204% | |
| -18.9904% | |
| -3.6718% | |
| 2.1802% | |
| 16.4076% | |
| 40.9986% | |
| 4.1005% | |
| -11.4549% | |
| 0.4882% | |
| -5.6485% | |
| -7.9035% | |
| -6.5122% | |
| 17.3402% | |
| 14.5944% | |
| -16.8495% | |
| 9.0331% | |
| 32.2342% | |
| -9.0853% | |
| 16.4174% | |
| -34.2697% | |
| 78.2228% | |
| -24.9765% | |
| -2.8285% | |
| 21.2837% | |
| 47.819% | |
| -69.5703% | |
| 315.6552% | |
| -21.4518% | |
| 1.4286% | |
| 26.4767% | |
| 5.3441% | |
| 85.0949% | |
| 191,091.7098% | |
| 0% |